Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-05-09
2008-09-16
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C558S303000, C558S388000, C514S579000, C514S646000
Reexamination Certificate
active
07425580
ABSTRACT:
The present invention concerns compounds of formula:where R1, R2, R3and R4are defined in the specification.
REFERENCES:
patent: 5789427 (1998-08-01), Chen et al.
patent: 5929117 (1999-07-01), Muller et al.
patent: 2001/0002391 (2001-05-01), Brand et al.
patent: 2003/0045726 (2003-03-01), Muller et al.
patent: 2003/0087955 (2003-05-01), Miller et al.
patent: 1 018 514 (2000-07-01), None
patent: 96/40137 (1996-12-01), None
patent: 99/65449 (1999-12-01), None
patent: 99/65495 (1999-12-01), None
patent: 00/56706 (2000-09-01), None
patent: 01/00610 (2001-01-01), None
patent: 01/30774 (2001-05-01), None
patent: 01/77055 (2001-10-01), None
patent: 03/051805 (2003-06-01), None
Latif et al (1974): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 1974:463372.
Cefalu, W., “The Use of Hormone Replacement Therapy in Postmenopausal Woman with Type 2 Diabetes,”J Womens Health&Gender-based Med., 2001, 10(3), 241-255.
Yuan et al., “Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption ofIkkβ,”Science, 2001, 293, 1673-7.
Pelletier et al., “Osteoarthritis, an Inflammatory Disease,”Arthr.&Rheum., 2001, 44:1237-1247.
Felson, D. T. et al., “The effects of estrogen on osteoarthritis,”,Curr Opinion Rheum, 1998, 10, 269-272.
Lin, C. C. et. al., “Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats,”Immunol. Lett., 2000, 73, 57-64.
Roth, A. et. al., “Phytoestrogen Kaempferol (3,4′ ,5,7-Tetrahydroxylflavone) Protects PC12 and T47D Cells From β-Amyloid-Induced Toxicity,”J. Neurosci. Res., 1999, 57, 399-404.
Bauer M. A., Herrmann F., “Interleukin-6 in clinical medicine,”Ann. Hematol., 1991, 62, 203-210.
Kurebayashi S. et. al., “Characterization of Mechanisms of Interleukin-6 Gene Repression by Estrogen Receptor,”J. Steroid Biochem. Molec. Biol., 1997, 60, 11-17.
Adams, M. R. et al., “Inhibition of Coronary Artery Atherosclerosis by 17-beta Estradiol in Ovariectomized Monkeys,”Arterio., 1990, 10(6), 1051-1057.
Sullivan, T. R. et al. “Estrogen Inhibits the Response-to-Injury in a Mouse Carotid Artery Model,”J. Clin. Invst., 1995, 96, 2482-8.
Nathan, L. et. al., “Estradiol Inhibits Leukocyte Adhesion and Transendothelial Migration in Rabbits In Vivo,”Circ. Res., 1999, 85, 377-385.
Delyani, J. A. et al., “Protection from Myocardial Reperfusion Injury by Acute Administration of 17 β-Estradiol,”J. Molec. Cell. Cardiol., 1996, 28, 1001-1008.
Reis et. al., “Estrogen Is Associated With Improved Survival in Aging Women With Congestive Heart Failure: Analysis of the Vesnarinone Studies,”J. Am. Coll. Cardio., 2000, 36, 529-33.
Grodstein, F. et. al., “A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease,”Ann. Int. Med., 2000, 133, 933-41.
Alexander et. al., “Initiation of Hormone Replacement Therapy After Acute Myocardial Infarction Is Associated With More Cardiac Events During Follow-Up,”J. Am. Coll. Cardio., 2001, 38, 1-7.
Grodstein F. et. al., “Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study,”Ann. Int. Med, 2001, 135,1-8.
Schonknecht, P. et. al., “Reduced cerebrospinal fluid estradiol levels are associated with increased β-amyloid levels in female patients with Alzheimer's disease,”Neurosci. Lett., 2001, 307, 122-124.
Hulley, S. et. al., “Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Woman,”J. Am. Med. Assoc., 1998, 280, 605-13.
Gupte, S. D. et al., “Synthesis of diaryl methylmalonates and analogous compounds,”J Organic Chem, 1959, 24, 1334-1336.
Y. Sumida, “Functional Polymers. VII. Ethyl 4-Vinyl-α-cyano-β-phenylcinnamate,”Polymer Journal(1981) 13, 521-536.
W. Lehnert, “Verbesserte Variante Der Knoevenagel-Kondensation MIT TiCl4/THF/Pyridin(1). Alkyliden- und Arylidenmalonester bei 0—25° C.,”Tetrahedron Lett.(1970), 54, 4723.
J. Simpson, “New solid phase Knoevenagel catalyst,”Tetrahedron Lett., (1999), 40, 7031-7033.
Latif, N., “Naphthalenes. Naphthyl-cyanoalkanoates, -cyanoalcohols and —malonamic acids of Anticipated Broad Spectrum Biological Activity,”Egypt J. Chem(1974) 17, 879-887.
Latif, N. et al. “Synthesis of Malononitriles of Potential Cystostatic and Pesticidal Activity by Reaction of Grignard Reagents with Ylidenemalononitriles,”J. Chem Soc., Perkin Trans. I, 1974, 8, 875-879.
Fadda, A. A. et al., “Synthesis of some phenanthrene derivatives structurally related to certain analgesic and antipyretic drugs,”Ind. J. Chem(1990) 29B, 171-173.
El-Hashash, M. et al., “Some Reactions with Arylidene Malononitrile, Malonic Acid and Malonic Ester,”Pakistan J. Sci. Ind. Res., 1977, 20(6), 325-329.
Mizuno et al, “Regioselective Double Vicinal Carbon-Carbon Bond-Forming Reactions of Electron-Deficient Alkenes by Use of Allylic Stannanes and Organoiodo Compounds,”J. Am Chem Soc1988 110, 1288-1290.
Yagi, K., “Short Communications. A Simple Fluorometric Assay for Lipoperoxide in Blood Plasma,”Biochemical Medicine15: 212-216 (1976).
Shughrue, P. J. et al., “Regulation of Progesterone Receptor Messenger Ribonucleic Acid in the Rat Medial Preoptic Nucleus by Estrogenic and Antiestrogenic Compounds: An in Situ Hybridization Study,”Endocrinology138: 5476-5484 (1997).
Merchenthaler, I. et al., The effect of estrogens and antiestrogens in a rat model for hot flush,Maturitas30: 307-316 (1998).
Cuzzocrea, S. et al., “17β-Estradiol Antiinflammatory Activity in Carrageenan-Induced Pleurisy,”Endocrinology141: 1455-1463 (2000).
Zaulyanov, L. L. et al., “Glutamate Receptor Requirement for Neuronal Death from Anoxia-Reoxygenation: An in Vitro Model for Assessment of the Neuroprotective Effects of Estrogens,”Cellular&Molecular Neurobiology19: 705-718 (1999).
Prokai, L. et al., “Synthesis and Biological Evaluation of 17β-Alkoxyestra-1,3,5(10)-trienes as Potential Neuroprotectants Against Oxidative Stress,”J. Med. Chem.44: 110-114 (2001).
A. R. Poole and R. R. A. Coombs, “Rheumatoid-Like Joint Lesions in Rabbits Injected Intravenously with Bovine Serum,”International Archives of Allergy&Applied Inmunology54: 97-113 (1977).
Mankin, H. J. et al., “Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips,”Journal of Bone&Joint Surgery—American vol. 53: 523-537 (1971).
Smirnoff, P. et al., “The Protective Effect of Estrogen Against Chemically Induced Murine Colon Carcinogenesis Is Associated With Decreased CpG Island Methylation and Increased mRNA and Protein Expression of the Colonic Vitamin D Receptor,”Oncology Research11: 255-264 (1999).
Dubal, D. B. et al., “Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury,”PNAS, USA98: 1952-1957 (2001).
Dubal, D. B. et al., “Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors,”J. Neurosci.19: 6385-6393 (1999).
Lundeen, S. G. et al., “Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone,”J. Steroid Biochem.Biol. 78: 137-143 (2001).
Stetson, S. J. et al., “Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor- α,”Circulation104: 676-681 (2001).
Dietrich, H. et al., “Mouse Model of Transplant Arteriosclerosis,”Arterio
Brazzale Antony Aldo
Caggiano Thomas Joseph
Pepper Hamilton LLP
Shameem Golam M
Wyeth
LandOfFree
(Diaryl-methyl)-malononitriles and their use as estrogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (Diaryl-methyl)-malononitriles and their use as estrogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Diaryl-methyl)-malononitriles and their use as estrogen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3971786